To test whether HOXA9 binding to the promoter region of WNT6 activates its expression, we performed WNT6 qRT‐PCR in GBM cell models engineered to overexpress or silence HOXA9 expression (Costa et al., 2010; Pojo et al., 2015). Here, WNT6 is linked to glioblastoma.